Unknown or multiple non-specific cellular components and pathways

The term 'Unknown or multiple non-specific cellular components and pathways' serves as a categorical placeholder in pharmacological databases for therapeutic agents that do not interact with a single, well-defined molecular target like a specific receptor or enzyme (1). This classification is often applied to drugs that act through general physical-chemical properties, such as osmotic diuretics that shift fluid balance or antacids that neutralize gastric pH (2). It is also frequently used for compounds discovered via phenotypic screening where the specific protein interactor has not yet been identified through target deconvolution (3). Because these agents lack a specific binding pocket, their biological activity is often broad and can involve multiple simultaneous pathways or structural components of the cell. This lack of specificity poses significant challenges for drug design and safety assessment, as it is difficult to predict or mitigate off-target interactions (1). Consequently, this category highlights a gap in current molecular understanding or represents a fundamentally different pharmacological approach compared to modern targeted therapies (3).

Other names

Unknown targetNon-specific mechanism of actionUnidentified cellular componentsPhenotypic target (unspecified)Non-protein target

Drugs associated with this classification typically exert their effects through non-specific physical or chemical interactions, such as altering osmotic pressure, neutralizing acidity, or non-selectively disrupting lipid bilayer integrity (1).